Alkermes plc. ($ALKS)
Filing Information
| Accession Number | 0001520262-26-000103 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
19,000
Total Value
$560,320.77
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP R&D, Chief Medical Officer | Ordinary Shares | โ | Jul 1, 2026 | Exercise/Conversion | 5,000 | $19.34 | $96,700.00 | 82,389 | Direct | โ | View Details | |
EVP R&D, Chief Medical Officer | Ordinary Shares | โ | Jul 1, 2026 | Sale | 8,300 | $51.46 | $427,128.79 | 74,089 | Direct | โ | View Details | |
EVP R&D, Chief Medical Officer | Ordinary Shares | โ | Jul 1, 2026 | Sale | 700 | $52.13 | $36,491.98 | 73,389 | Direct | โ | View Details | |
EVP R&D, Chief Medical Officer | Employee Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 1,356 | Direct | โ | View Details |